Clinical Trial Update: Prometa Pharmacotherapy for Methamphetamine Dependence [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial evaluating Prometa Pharmacotherapy for methamphetamine dependence (drug abuse/dependence).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Use Disorder
• Substance Use Disorder

Drugs mentioned

• Prometa Pharmacotherapy

Snippet

Sponsor: University of California, Los Angeles | Conditions: Drug Abuse, Drug Dependence | Phase 2, Phase 3 | Status: COMPLETED